Massey K. serves as Chief Operating Officer of argenx SE, a biopharmaceutical company based in the Netherlands. As an executive subject to EU Market Abuse Regulation disclosure requirements, K. is obligated to report securities transactions. Two such regulated disclosures have been publicly filed.
Transactiegeschiedenis
0 signaaltransactiesZijde
Geen gemelde transacties gevonden.